Article info

Download PDFPDF

Original research
Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects

Authors

  1. Correspondence to Dr Catherine Overed-Sayer, Regeneration, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB21 6GH, United Kingdom; catherine.overed-sayer{at}astrazeneca.com
View Full Text

Citation

Overed-Sayer C, Miranda E, Dunmore R, et al
Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects

Publication history

  • Received August 21, 2019
  • Revised April 17, 2020
  • Accepted May 1, 2020
  • First published July 24, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.